<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>Pelargonium sidoides</italic> (
 <italic>P. sidoides</italic>) belongs to the family of 
 <italic>Geraniaceae</italic> and is commonly known as Umckaloabo [
 <xref rid="B191-plants-09-01244" ref-type="bibr">191</xref>]. It is found all over the world and roots of this plant are traditionally used for remedial purposes against tuberculosis, respiratory diseases, cough, gastrointestinal infection, viral diseases and others [
 <xref rid="B191-plants-09-01244" ref-type="bibr">191</xref>,
 <xref rid="B193-plants-09-01244" ref-type="bibr">193</xref>]. 
 <italic>P. sidoides</italic> roots are known to have some potent compounds, such as methoxycoumarin, proanthocyanidins and prodelphinidins [
 <xref rid="B192-plants-09-01244" ref-type="bibr">192</xref>]. Furthermore, its roots are also used for the production of herbal drugs known as EPs 7639 by ethanolic extract, which have been approved for the treatment of respiratory tract infections [
 <xref rid="B191-plants-09-01244" ref-type="bibr">191</xref>,
 <xref rid="B194-plants-09-01244" ref-type="bibr">194</xref>]. According to Theisen et al., 2012, 
 <italic>P. sidoides</italic> also has the potential to inhibit the viral entry of the influenza virus [
 <xref rid="B194-plants-09-01244" ref-type="bibr">194</xref>]. Therefore, it is suggested that roots of 
 <italic>P. sidoides</italic> should be further investigated for the treatment of COVID-19.
</p>
